| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.003 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.29 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.27 | 0.3 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.26 | 0.08 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.23 | 0.09 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.21 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.2 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.004 |